MedTrace Logo

Development of Magnetic Resonance (MR) Simulation for Treatment Planning

NCT00314496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-02-25

No results posted yet for this study

Summary

Retrospectively have access to MR images of patients to develop software that:

1. segment images
2. convert MR values to electron density and then
3. entered into a dose calculation system

The project involves software development of data that is already available. No intervention is made at this point.

Conditions

  • Healthy

Sponsors & Collaborators

  • Cross Cancer Institute

    collaborator OTHER

  • AHS Cancer Control Alberta

    lead OTHER

Principal Investigators

  • Gino Fallone, PhD · AHS Cancer Control Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00314496 on ClinicalTrials.gov